Advertisement

Multiple Sclerosis: Phenotypic Immunogenetic Markers and Nucleic Acid Biochemistry

  • H. Zander
Conference paper

Abstract

Twelve years ago, in 1974, the earliest use of the term “DNA probe” was made by Murphy and Attardi [19]. Since then, probes have rapidly propagated into every field of biology and medicine. In current practice, probes make it easier to determine genotype than phenotype. The approach to multiple sclerosis (MS) as proposed herein, although tremendously laborious, should provide the means of moving from linked marker genes to the very true genes that confer susceptibility to MS. The next step should be to sequence the susceptibility genes, to delineate their gene products — i.e., to identify the molecules that are involved in the pathogenesis — to studv their function, and — ultimately — to provide a molecular basis for therapy.

Keywords

Multiple Sclerosis Spastic Paraparesis Definite Multiple Sclerosis Interferon Production Multiple Sclerosis Susceptibility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abb J, Kaudewitz T, Zander E, Ziegler HWL, Deinhardt F, Riethmüller G (1982) Interferon production and natural killer cell acitivity in patients with multiple sclerosis: influence of genetic factors assessed by studies of monozygotic twins. In: Herberman RB (ed) NK cells and other natural effector cells. Academic, New York, pp 1233–1240Google Scholar
  2. 2.
    Alter M, Harshe M, Anderson VE, Emme L, Yunis EJ (1976) Genetic association of multiple sclerosis and HL-A determinants. Neurology (Minneap) 26:31–36Google Scholar
  3. 3.
    Batchelor JR, Compston A, McDonald WI (1978) HLA and multiple sclerosis. Br Med Bull 34:279–284PubMedGoogle Scholar
  4. 4.
    Benczur M, Petrányi GG, Pálffy G, Varga M, Tälas M, Kotsy B, Földes I, Hollán SR (1980) Dysfunction of NK cells in multiple sclerosis. PNAS 76:657–662Google Scholar
  5. 5.
    Bertrams J, Kuwert F (1974) HL-A-antigen segregation analysis in multiple sclerosis. Lancet ii: 43–44Google Scholar
  6. 6.
    Broman T, Bergmann L, Andersen A (1974) Conclusional report. The international symposium on multiple sclerosis, Göteborg, Sept. 1972. Acta Neurol Scand [Suppl. 58] 50:69–89Google Scholar
  7. 7.
    Cohen D, Cohen O, Marcadet A, Massart C, Lathrop M, Deschamps I, Hors J, Schuller E, Dausset J (1984) Class II HLA-DC β-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. PNAS 81:1774–1778PubMedCrossRefGoogle Scholar
  8. 8.
    Dausset J, Cohen D (1984) HLA at the gene level. In: Mayr WR, Albert ED, Baur MP (eds), Histocompatibility testing 1984. Springer, Berlin Heidelberg New York, pp 22–28Google Scholar
  9. 9.
    Ebers GC, Paty DW, Stiller CR, Nelson RF, Seland TP, Larsen T (1982) HLA-typing in multiple sclerosis sibling pairs. Lancet II: 88–90Google Scholar
  10. 10.
    Francis DA, Batchelor JR, McDonald WI, Hera JEC, Downie AW (1986) Multiple sclerosis and HLA-DQwl. Lancet 1:211PubMedCrossRefGoogle Scholar
  11. 11.
    Haile RW, Iselius L, Hodge SE, Morton NE, Detels R (1981) Segregation and linkage analysis of 40 multiplex multiple sclerosis families. Hum Hered 31:252–258PubMedCrossRefGoogle Scholar
  12. 12.
    Hauser SL, Ault KA, Levin JJ, Garovoy MR, Weiner HL (1981) Natural killer cell activity in multiple sclerosis. J Immunol 127:1114–1117PubMedGoogle Scholar
  13. 13.
    Hens L, Carton H (1978) HL-A determinants and familial multiple sclerosis. Tissue Antigens 11:75–80PubMedCrossRefGoogle Scholar
  14. 14.
    Kaudewitz P, Zander H, Abb J, Ziegler-Heitbrock HWL, Riethmuller G (1983) Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis; Studies in monozygotic discordant twins. Hum Immunol 7:51–58PubMedCrossRefGoogle Scholar
  15. 15.
    Kratzin H, Yang Ch, Götz H, Pauly E, Kölbel S, Egert G, Thinnes FP, Wernet P, Altevogt P, Hilschmann J (1981) Aminosôuresequenz der iV-terminalen 198 Reste der β-Kette des HLA-DW2,2;DR2,2-Alloantigens. Hoppe-Seyler’s D Physiol Chem 362:1665–1669Google Scholar
  16. 16.
    Kurtzke JK (1970) Neurologic impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand 46:493–512PubMedCrossRefGoogle Scholar
  17. 17.
    Martell M, Marcadet A, Strominger J, Dausset J, Cohen D (1986) Germ line E i alpha gene related polymorphism contributes to genetic susceptibility to multiple sclerosis. Immunobiol 173:496Google Scholar
  18. 18.
    McDonald WI, Batchelor JR, Francis DA (1984) The immunogenetics of multiple sclerosis. Trends Neuro Sci 7:369–371CrossRefGoogle Scholar
  19. 19.
    Murphy WI, Attardi G (1974) Use of a DNA probe for mapping by electron microscopy the ribosomal sequence in ribosomal RNA precursors from duck cells. J Mol Biol 90:65–69PubMedCrossRefGoogle Scholar
  20. 20.
    Naito S, Namerow A, Mickey MR, Terasaki PI (1972) Multiple sclerosis: association with HL-A3. Tissue Antigens 2:1–4PubMedCrossRefGoogle Scholar
  21. 21.
    Neighbour PA, Bloom BR (1979) Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. PNAS 76:476–480PubMedCrossRefGoogle Scholar
  22. 22.
    Nerl Chr, Zander H, Albert ED, Valet G (1980) Serum levels of C2, C3, and C4 complement components in HLA-A,B,C,DR-typed multiple sclerosis sibpair doublecase families. Immunobiol 157:257–258Google Scholar
  23. 23.
    Olsson JE, Möller R, Link Y (1976) HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol 33:808–812PubMedGoogle Scholar
  24. 24.
    Pandey JP, Goust J-M, Salier J-P, Fudenberg HH (1981) Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. J Clin Invest 67:1797–1800PubMedCrossRefGoogle Scholar
  25. 25.
    Penrose LS (1935) The detection of autosomal linkage in data which consist of pairs of brothers and sisters of unspecified parentage. Ann Eugen 6:133–138CrossRefGoogle Scholar
  26. 26.
    Propert DN, Bernard CC, Simons MJ (1982) Gm allotypes and multiple sclerosis. J Immunogen 9:359–361CrossRefGoogle Scholar
  27. 27.
    Refsum S, Skre H (1978) Neurological approaches to the inherited ataxias. Adv Neurol 21:1–13PubMedGoogle Scholar
  28. 28.
    Rose AS, Ellison GW, Myers LW, Tourtellotte WW (1976) Criteria for the clinical diagnosis of multiple sclerosis. Neurology 26:20–22PubMedGoogle Scholar
  29. 29.
    Roses AD (1984) Book review: recombinant DNA applications to human disease (Banbury Report 14). Trends Neuro Sci 7:264–265CrossRefGoogle Scholar
  30. 30.
    Santoli D, Hall W, Kastrukoff L, Lisak RP, Perussia B, Trinchieri G, Koprowski H (1981) Cytotocix activitiy and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol 126:1274–1278PubMedGoogle Scholar
  31. 31.
    Schmidtke J, Cooper DN (1986) The list of cloned human DNA sequences. Gene Communications II: 3Google Scholar
  32. 32.
    Schröder R, Zander H, Andreas A, Mauff G (1983) Studies on the association of multiple sclerosis with C2, C4, Bf, C3, C6 and GLO polymorphisms. Immunobiology 164:160–170PubMedCrossRefGoogle Scholar
  33. 33.
    Tiwari JL, Morton NE, Lalouel JM, Terasaki PI, Zander H, Hawkins BR, Cho YW (1980) Multiple sclerosis. Joint Report. In: Terasaki PI (ed) Histocompatibility testing 1980, The Regents of the University of California, Los Angeles, pp 687–692Google Scholar
  34. 34.
    Tiwari JL, Terasaki PI (1985) Multiple sclerosis. In: Tiwari JL, Terasaki PI (eds) HLA and disease associations. Springer, New York Berlin Heidelberg Tokyo, pp 162–167Google Scholar
  35. 35.
    Zander H (1985) Clinical and immunogenetic data of 33 double case families with multiple sclerosis: a starting point for further analyses on the DNA level. In: Hommes OR (ed) Multiple sclerosis research in Europe. MTP, Lancaster, pp 333–336Google Scholar
  36. 36.
    Zander H, Kuntz B, Scholz S, Albert ED (1976) Multiple sclerosis. Analysis for joint segregation with HLA, a family study. In: Dausset J, Svejgaard A (eds) HLA and disease, vol.58. INSERM, Paris, 191Google Scholar
  37. 37.
    Zander H, Scholz S, Kuntz B, Albert ED (1980) A sib-pair double case study of the genetics of multiple sclerosis. An interim report on 34 pairs of affected siblings. In: Bauer HJ, Poser S, Ritter G (eds) Progress in multiple sclerosis research. Springer, Berlin Heidelberg New York, pp 485–489Google Scholar
  38. 38.
    Zander H, Scholz Albert ED (1980) Multiple sclerosis disease study: HLA-A, B, C and DRw haplotypes in 13 sib-pair double cases families from West Germany. In: Terasaki PI (ed), Histocompatibility testing 1980. The Regents of the University of California, Los Angeles, 1947Google Scholar
  39. 39.
    Zander H, Kaudewitz P, Abb J, Riethmüller G (1982) Natural killer cells and interferon production in multiple sclerosis: studies in discordant HLA-identical siblings and monozygotic twins. In: Taskos NA (ed) Proc. IV. south-east European neuropsychiatric conference, Hal-kidiki, Greece, 1981; Vol. III, multiple sclerosis, University Studio Press, Thessaloniki, pp 43–54Google Scholar
  40. 40.
    Zander H, Abb J, Kaudewitz P, Riethmüller G (1982) Natural killing activity and interferon production in multiple sclerosis. Lancet 1:280PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • H. Zander
    • 1
  1. 1.Laboratory of Immunogenetics, KinderpoliklinikUniversity of MunichMunichGermany

Personalised recommendations